Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Clinical trial NCT03465540 · TERMINATED

Trial details

NCT number: NCT03465540
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Acute Myeloid Leukemia Non-Hodgkins Lymphoma Myelodysplastic Syndrome AML MDS NHL

Start date: 2018-08-17
Primary completion: 2019-07-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.